Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
1239908-20-3
InChi: InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H
5R)-2-(hydroxymethyl)-5-[6-(methylamino)-9H-purin-9-yl]oxolane-3
InChi: InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20
NS-304 Size:Solid 2 mg 1239908-20-3Selexipag, also known as ACT 293987 and NS 304, is a a first in class orally available selective non prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT 333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. Product information CAS Number: 475086 01 2 Molecular Weight: 496. 62
US$ 19.00
US$ 20.00
US$ 13.00